St Jude Medical Inc (STJ)

80.82
0.13 0.16
NYSE : Health Care
Prev Close 80.69
Open 80.80
Day Low/High 80.72 / 81.31
52 Wk Low/High 48.83 / 84.00
Volume 14.74M
Avg Volume 2.67M
Exchange NYSE
Shares Outstanding 285.72M
Market Cap 23.09B
EPS 3.10
P/E Ratio 35.39
Div & Yield 1.24 (1.50%)

Latest News

Jim Cramer: Drug Stocks Feeling Political Pressure

Jim Cramer: Drug Stocks Feeling Political Pressure

Political pressure is weighing on drug and medical device stocks including Abbott Labs and St. Jude, says Jim Cramer.

What to Watch on Wall Street This Week: Netflix Earnings, Fed Speakers

What to Watch on Wall Street This Week: Netflix Earnings, Fed Speakers

Investors will get a slew of earnings reports from major companies and a host of Federal Reserve speakers during the week of Oct. 17.

Closing Bell: FCC Hits Comcast With Fine; U.S. Stocks Sell Off

Closing Bell: FCC Hits Comcast With Fine; U.S. Stocks Sell Off

U.S. stocks bottom out during Tuesday afternoon's session as a disappointing quarterly performance from Alcoa heralds a poor start to the third-quarter earnings season.

Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide

Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide

On days like this, the money just keeps sloshing around.

St. Jude Shares Slip on Defibrillator Battery Warning

St. Jude Shares Slip on Defibrillator Battery Warning

Many investors were exiting their investments in the medical-device giant on news of the warning.

Jim Cramer: St. Jude Battery Woes Big But Not a Dealbreaker

Jim Cramer: St. Jude Battery Woes Big But Not a Dealbreaker

St. Jude's warning about battery risks in its implanted heart devices are big but will likely not disrupt its deal with Abbott Labs.

Morning Movers: ILMN, STJ, AA, MRO, CHK

Morning Movers: ILMN, STJ, AA, MRO, CHK

Shares of Illumina were tanking before the opening bell after unveiling a disappointing sales forecast.

Vigorous M&A Activity Signals Economic Health

Vigorous M&A Activity Signals Economic Health

Despite markets at record highs, companies are satisfying their appetites to grow and find value by buying others.

4 Market Segments to Avoid

4 Market Segments to Avoid

These sectors are full of high-priced, low-growth stocks.

Jim Cramer Says Abbott's Acquisition of St. Jude Medical Could be in Trouble

Jim Cramer Says Abbott's Acquisition of St. Jude Medical Could be in Trouble

Jim Cramer says whether or not Abbott completes its acquisition of St. Jude remains to be seen.

St. Jude Medical Shares Fall as Muddy Waters Unveils Short Position

St. Jude Medical Shares Fall as Muddy Waters Unveils Short Position

Shares of the medical device manufacturer fell on a dismal outlook from Muddy Waters.

Closing Bell: Micron Jumps on Shortage Forecasts; U.S. Stocks Fall

Closing Bell: Micron Jumps on Shortage Forecasts; U.S. Stocks Fall

U.S. stocks broke into the red by mid-afternoon after a choppy morning spent riding the flatline.

Trending Tickers: MU, HPQ, WDC, STJ

Trending Tickers: MU, HPQ, WDC, STJ

Data-storage companies got a boost on news a supply shortage could be looming.

Cramer: Worst May Be Over for Embattled Pharma

The M&A activity is an incredible and a welcome sign.

Jim Cramer: I’m a Huge Backer of Abbott Labs CEO Miles White

Jim Cramer: I’m a Huge Backer of Abbott Labs CEO Miles White

Jim Cramer is bullish on Abbott Laboratories' acquisition of St. Jude Medical.

U.S. Stocks Slip on Sluggish GDP; Ford Posts Record Profit

U.S. Stocks Slip on Sluggish GDP; Ford Posts Record Profit

U.S. stocks dropped on Thursday, as first quarter gross domestic product came in weaker than expected.

St. Jude downgraded at BTIG

St. Jude upgraded at Canaccord

St. Jude Medical downgraded at Wells

Stocks to Watch for 2016 M&A Deals

Stocks to Watch for 2016 M&A Deals

Look for 2015's record run of mergers and acquisitions to continue.

St. Jude numbers reduced at Jefferies

Jim Cramer Says Buy Celgene at $113 or Below, Skyworks in the $70s

Jim Cramer Says Buy Celgene at $113 or Below, Skyworks in the $70s

Jim Cramer answered viewers' Twitter from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO), Celgene (CELG), and Boston Scientific (BSX).

Jim Cramer Says Retail Investors Should Wait to Buy Stocks

Jim Cramer Says Retail Investors Should Wait to Buy Stocks

Stocks climbed early Thursday, but Jim Cramer, portfolio manager of Action Alerts PLUS, remains cautious still.

St. Jude downgraded at BMO

St. Jude downgraded at Deutsche

Microsoft Cut Down By Currency; Home Sales Hit 8-Year High

Microsoft Cut Down By Currency; Home Sales Hit 8-Year High

Microsoft (MSFT) shares fell after revenue projections came in weaker than expected.

Market Wrap: IBM and United Tech a Real Drag

IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..

Cramer Sees T-Mobile Pricing Impacts; Doesn't Recommends Gold ETFs

Cramer Sees T-Mobile Pricing Impacts; Doesn't Recommends Gold ETFs

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.